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In the last decade, the scientific community has been
shaken by what we call the “noncoding revolution.” We have
witnessed the discovery of an increasing amount of RNA
molecules, which play a critical role in normal physiology
as well as disease, without providing any protein product.
The smallest regulatory RNA species, known as the ∼22
nucleotide-long microRNAs (miRNAs), were at the forefront
of such a revolution.
According to the last release of miRNA database (miR-
Base http://www.mirbase.org—release 21) more than 35,000
miRNA species have been identified, of which a total of more
than 2,500 mature miRNAs exist only in humans [1]. Since
their first discovery in C. elegans in 1993, it has become
clear that these tiny molecules have an enormous regulatory
potential, being able to exert negative posttranscriptional
regulation on hundreds of protein coding genes, even simul-
taneously, and ultimately act as master regulators of entire
biological processes.
Besides their role in development, the involvement of
miRNAs in human disease, and cancer in particular, has
attractedmajor attention. In fact, deregulatedmiRNAexpres-
sion could lead to aberrant expression of targeted oncogenes
or tumor suppressors, thus resulting in tumor development
and progression. Accordingly, altered expression of miRNAs
has been observed in almost every tumor type, including
haematological malignancies, carcinomas, sarcomas, and
central nervous system neoplasms. Relevant examples of the
role of miRNAs on specific cancer types are reported in
this issue, with a focus on childhood acute lymphoblastic
leukemia (original contribution by M. Duyu et al.), ovarian
and cervical cancer (reviewed by Y. Kinose et al. and S. M.
Dı´az-Gonza´lez et al.), soft tissue sarcomas (reviewed by T.
Fujiwara et al.), or medulloblastoma (reviewed by S. Lo´pez-
Ochoa et al.).
The unique pattern of altered miRNA expression pro-
vides a fingerprint that may serve for cancer diagnosis and
prediction of patient’s prognosis or response to treatment.
In addition, a number of miRNAs have been shown to
directly participate in tumorigenesis by acting as “oncoMirs”
or “tumor suppressive miRNAs,” thus becoming potential
key targets or tools for anticancer therapy. The review by
A. Saumet and colleagues suitably introduces the current
approaches and applications ofmiRNAs in cancer and human
diseases, from expression analyses aimed at identifying miR-
NAs potentially useful for tumor diagnosis or prognosis to
the potential use of them as novel therapeutic agents.
The opportunities and challenges of miRNAs as cancer
biomarkers have been addressed in the issue by H. Lan
and colleagues. Specific focuses have been also provided
on the clinicopathological significance of miR-155 in breast
cancer (H. Zeng et al.), diagnostic and prognostic miRNAs
in sarcomas (T. Fujiwara et al.), and miRNAs exploitable
for prostate cancer risk assessment (A. Cannistraci et al.).
Based on their relative stability in body fluids, a great
effort has been devoted in the last years to the study of
circulating miRNAs as noninvasive biomarkers for tumor
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diagnosis or disease monitoring. Though attracting, miRNA
quantification in liquid samples is far from being trivial.
Challenges encountered in the field have been extensively
addressed in the issue by P. Tiberio and colleagues.
Due to their nature as physiological molecules able to
control multiple genes at the same time, miRNAs are also
considered as very promising therapeutic targets or tools.
As tumors typically evade cancer treatment by acquiring
secondary mutations on targeted proteins, it appears more
difficult for a tumor to escape from miRNA effects, which
are directed on multiple proteins at the same time. Control-
ling the delivery and activity of miRNA-modulating agents
into specific tissues or organs still appears as the “the big
challenge,” albeit a number of promising approaches are
under validation. This contention is extensively explored in
this issue in different contexts. The review by O. Fortunato
et al. focuses on lung cancer, one of the big cancer killers,
and discusses the most likely miRNA targets as well as the
methodological approaches for in vivo delivery of miRNAs.
The use of miRNA modulators for a direct antitumor effect,
when administered alone or in combination with chemo- or
radiotherapy, has been described in the prostate cancer con-
text by A. Cannistraci and colleagues. Furthermore, the use
of miRNAs for indirect anticancer effects has been reviewed
by S. Gallach et al., who discussed on the possibility to
modulate miR-126 or miR-92a to target tumor angiogenesis,
thus limiting tumor growth and metastatic spread, or act
on hypoxia. Finally the role of miRNAs in determining and
regulating chemoresistance of pancreatic cancer has been
discussed by I. Garajova´ and colleagues.
Overall the issue is intended to provide evidence of the
potential usefulness of miRNAs in cancer management as
well as focus on the still unsolved technical and conceptual
challenges in miRNA research.
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